Cyclic derivatives as modulators of chemokine receptor activity
申请人:——
公开号:US20030004151A1
公开(公告)日:2003-01-02
The present application describes modulators of MCP-1 of formula (I):
1
or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.